| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:39:38 UTC |
|---|
| Update Date | 2022-03-07 02:52:44 UTC |
|---|
| HMDB ID | HMDB0030891 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one |
|---|
| Description | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive isoprene units. Based on a literature review a significant number of articles have been published on (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one. |
|---|
| Structure | CC(C)=CC(=O)C\C(C)=C\CC\C(C)=C\CO InChI=1S/C15H24O2/c1-12(2)10-15(17)11-14(4)7-5-6-13(3)8-9-16/h7-8,10,16H,5-6,9,11H2,1-4H3/b13-8+,14-7+ |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C15H24O2 |
|---|
| Average Molecular Weight | 236.3499 |
|---|
| Monoisotopic Molecular Weight | 236.177630012 |
|---|
| IUPAC Name | (6E,10E)-12-hydroxy-2,6,10-trimethyldodeca-2,6,10-trien-4-one |
|---|
| Traditional Name | (6E,10E)-12-hydroxy-2,6,10-trimethyldodeca-2,6,10-trien-4-one |
|---|
| CAS Registry Number | 79421-76-4 |
|---|
| SMILES | CC(C)=CC(=O)C\C(C)=C\CC\C(C)=C\CO |
|---|
| InChI Identifier | InChI=1S/C15H24O2/c1-12(2)10-15(17)11-14(4)7-5-6-13(3)8-9-16/h7-8,10,16H,5-6,9,11H2,1-4H3/b13-8+,14-7+ |
|---|
| InChI Key | VCXVMWVWGVWZPY-CCLLZULESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive isoprene units. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Sesquiterpenoids |
|---|
| Direct Parent | Sesquiterpenoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Sesquiterpenoid
- Farsesane sesquiterpenoid
- Fatty alcohol
- Fatty acyl
- Acryloyl-group
- Enone
- Alpha,beta-unsaturated ketone
- Ketone
- Primary alcohol
- Organooxygen compound
- Organic oxygen compound
- Alcohol
- Carbonyl group
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.88 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.2547 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.49 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2367.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 258.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 162.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 163.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 70.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 427.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 457.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 64.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1071.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 445.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 968.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 345.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 348.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 259.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 306.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,1TMS,isomer #1 | CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/CO[Si](C)(C)C | 1904.3 | Semi standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,1TMS,isomer #2 | CC(C)=CC(=C/C(C)=C/CC/C(C)=C/CO)O[Si](C)(C)C | 2034.2 | Semi standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,2TMS,isomer #1 | CC(C)=CC(=C/C(C)=C/CC/C(C)=C/CO[Si](C)(C)C)O[Si](C)(C)C | 2143.1 | Semi standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,2TMS,isomer #1 | CC(C)=CC(=C/C(C)=C/CC/C(C)=C/CO[Si](C)(C)C)O[Si](C)(C)C | 2107.9 | Standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,1TBDMS,isomer #1 | CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/CO[Si](C)(C)C(C)(C)C | 2132.3 | Semi standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,1TBDMS,isomer #2 | CC(C)=CC(=C/C(C)=C/CC/C(C)=C/CO)O[Si](C)(C)C(C)(C)C | 2260.1 | Semi standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,2TBDMS,isomer #1 | CC(C)=CC(=C/C(C)=C/CC/C(C)=C/CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2582.1 | Semi standard non polar | 33892256 | | (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one,2TBDMS,isomer #1 | CC(C)=CC(=C/C(C)=C/CC/C(C)=C/CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2507.6 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ul9-9740000000-b6f4a84750e10641d99a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one GC-MS (1 TMS) - 70eV, Positive | splash10-025l-9550000000-74359f715cb40e57df13 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 10V, Positive-QTOF | splash10-014r-1490000000-725b3d3f06c8cee83ba2 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 20V, Positive-QTOF | splash10-014r-6930000000-5ca45ceaf12b13bc6529 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 40V, Positive-QTOF | splash10-0pvi-9400000000-37555a8099405b24aad0 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 10V, Negative-QTOF | splash10-000i-0090000000-6a0a5b1e24378ae6e690 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 20V, Negative-QTOF | splash10-0a4r-5390000000-1c1763e4f179950e262e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 40V, Negative-QTOF | splash10-0a4i-9410000000-8a7c55d19caea3be3a13 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 10V, Negative-QTOF | splash10-000i-1190000000-822031d72213fbef7788 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 20V, Negative-QTOF | splash10-001a-5890000000-4d14c7f1b868b48b1f6e | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 40V, Negative-QTOF | splash10-01pk-9500000000-3799682da972fe53dd38 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 10V, Positive-QTOF | splash10-0fs9-4940000000-47505850ca928b078eae | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 20V, Positive-QTOF | splash10-053s-9710000000-eac1c77758621b966a91 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2E,6E)-1-Hydroxy-2,6,10-farnesatrien-9-one 40V, Positive-QTOF | splash10-0apl-9500000000-82c2c9200f67c8f2611a | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|